Chester Zygmont - La Jolla Director of Finance
LJPCDelisted Stock | USD 6.22 0.00 0.00% |
Director
Mr. Chester S. Zygmont, III is Director of Finance of La Jolla Pharmaceutical Company. Prior to becoming Director of Finance, he was a consultant for the Company in the same role since June 2012. Mr. Zygmont brings 10 years of experience in finance with a wide range of industry applications to the Company. Previously, Mr. Zygmont served as Managing Director at Z3 Capital, LLC. Z3 Capital, LLC is a privately held investment firm focused on investment acquisition and venture funding of startup real estate, medical device and biotechnology companies since 2013.
Age | 33 |
Tenure | 11 years |
Phone | 617 715-3600 |
Web | www.ljpc.com |
La Jolla Management Efficiency
The company has return on total asset (ROA) of 1.64 % which means that it generated a profit of $1.64 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0544 %, meaning that it created $0.0544 on every $100 dollars invested by stockholders. La Jolla's management efficiency ratios could be used to measure how well La Jolla manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 124.8 M in liabilities with Debt to Equity (D/E) ratio of 7.16, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. La Jolla Pharmaceutical has a current ratio of 3.84, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist La Jolla until it has trouble settling it off, either with new capital or with free cash flow. So, La Jolla's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like La Jolla Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LJPC to invest in growth at high rates of return. When we think about La Jolla's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Steven Gunby | Arrow Electronics | 63 | |
James Osborne | Ryanair Holdings PLC | 67 | |
Richard Donaldson | Lindblad Expeditions Holdings | 56 | |
Minhong Yu | Sunlands Technology Group | 54 | |
Garrett Camp | Uber Technologies | 44 | |
Gail Hamilton | Arrow Electronics | 71 | |
Daniel Hanrahan | Lindblad Expeditions Holdings | 60 | |
Edward Wilson | Ryanair Holdings PLC | 53 | |
Declan McKeon | Ryanair Holdings PLC | 66 | |
Louise Phelan | Ryanair Holdings PLC | 50 | |
Laurel Krzeminski | Arrow Electronics | 66 | |
Zheng Zhao | Sunlands Technology Group | 41 | |
Lv Lu | Sunlands Technology Group | 35 | |
John Thain | Uber Technologies | 65 | |
Charles McCreevy | Ryanair Holdings PLC | 67 | |
John Fahey | Lindblad Expeditions Holdings | 66 | |
Lawrence Calcano | Lindblad Expeditions Holdings | 53 | |
Stephen Patrick | Arrow Electronics | 71 | |
Andrew Kerin | Arrow Electronics | 57 | |
William Patton | Verra Mobility Corp | 70 | |
Harvey Eads | Visionary Education Technology | 73 |
Management Performance
Return On Equity | 0.0544 | |||
Return On Asset | 1.64 |
La Jolla Pharmaceutical Leadership Team
Elected by the shareholders, the La Jolla's board of directors comprises two types of representatives: La Jolla inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LJPC. The board's role is to monitor La Jolla's management team and ensure that shareholders' interests are well served. La Jolla's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, La Jolla's outside directors are responsible for providing unbiased perspectives on the board's policies.
George Tidmarsh, President CEO, Secretary, Director | ||
Saiid Zarrabian, Independent Chairman of the Board | ||
James Rolke, VP of RandD | ||
Chester Zygmont, Director of Finance | ||
Craig Johnson, Independent Director | ||
Jennifer Carver, Senior Vice President Operations | ||
Robert Rosen, Director | ||
Lakhmir Chawla, Chief Medical Officer | ||
Laura Douglass, Independent Director | ||
Dennis Mulroy, CFO | ||
Darryl Wellinghoff, Chief Commercial Officer |
LJPC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is La Jolla a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0544 | |||
Return On Asset | 1.64 | |||
Profit Margin | 10.08 % | |||
Operating Margin | 4.68 % | |||
Current Valuation | 242.85 M | |||
Shares Outstanding | 27.52 M | |||
Shares Owned By Insiders | 1.91 % | |||
Shares Owned By Institutions | 71.79 % | |||
Number Of Shares Shorted | 202.51 K | |||
Price To Earning | 38.88 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in LJPC Stock
If you are still planning to invest in La Jolla Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the La Jolla's history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |